Stay updated on Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page.

Latest updates to the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page
- Check2 days agoChange DetectedA new PubMed publication citation was added to Publications, and the page revision tag was updated from v3.5.3 to v3.5.4.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision: v3.5.3 replaces v3.5.2 on the page, indicating a minor update to the page template/metadata. No content or study data appears to be changed.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2, likely reflecting minor internal fixes or improvements to the platform.SummaryDifference0.0%

- Check38 days agoChange DetectedNew Turkish study locations (Ankara and Samsun) and a 'Results Posted' entry have been added, and several earlier Turkish sites were removed or updated.SummaryDifference2%

- Check45 days agoChange DetectedAdded the CEPHEUS trial citation from Nat Med (2025) and removed the Erratum notice for that article.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded Results Submitted and Revision: v3.5.0; removed No Results Posted and Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page.